Literature DB >> 6519179

Changes in central monoaminergic function during chronic treatment with clonidine in the spontaneously hypertensive rat.

J Atkinson, M Sonnay, N Boillat.   

Abstract

Clonidine was administered intravenously via osmotic minipumps at doses of 0.1 and 0.5 mg X kg-1 X 24 h-1. Both doses lowered blood pressure to the same degree by the third day of treatment. Only the higher dose significantly lowered heart rate. There was no tolerance to these cardiovascular effects which were maintained up to the seventh day of clonidine infusion. The only clonidine-induced change in central monoaminergic function was an increase in the adrenaline levels in the hindbrain. No other changes in central monoaminergic function in either cortex or hindbrain were detected at the level of the enzymes (tyrosine hydroxylase) of the neurotransmitters (noradrenaline, dopamine) or of the adrenoceptors [( 3H]clonidine binding). Our results suggest that clonidine lowers blood pressure via inhibition of release of hindbrain adrenaline.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6519179     DOI: 10.1016/0014-2999(84)90066-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Aggravation of the severity of the clonidine withdrawal syndrome in conscious rats by beta 2-adrenoceptor antagonists.

Authors:  F A Jonkman; P A van Zwieten
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  Biochemical evidence that brainstem adrenaline-containing neurons are activated during clonidine withdrawal in the spontaneously hypertensive rat.

Authors:  L Lambás-Señas; J Atkinson; J P Fluckiger; M Sonnay; G Chamba; B Renaud
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

3.  Effect of prolonged clonidine treatment and its withdrawal on noradrenaline turnover in the cerebral cortex and medulla oblongata of the spontaneously hypertensive rat.

Authors:  J Atkinson; N Boillat; T Dennis; S Z Langer; B Scatton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

4.  The cardiovascular actions of clonidine and neuropeptide-Y in the ventrolateral medulla of the rat.

Authors:  M A McAuley; I M Macrae; J L Reid
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.